Search

Your search keyword '"CHANNER, KEVIN S."' showing total 6 results
Start Over Author "CHANNER, KEVIN S." Publisher american diabetes association
6 results on '"CHANNER, KEVIN S."'

1. Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study)

Author

Jones, T. Hugh, Arver, Stefan, Behre, Hermann M., Buvat, Jacques, Meuleman, Eric, Moncada, Ignacio, Morales, Antonio Martin, Volterrani, Maurizio, Yellowlees, Ann, Howell, Julian D., and Channer, Kevin S.

Subjects
Bayer AG, Eli Lilly and Co., Tanita Corp., Lipids -- Physiological aspects, Cholesterol -- Physiological aspects, Medical research -- Physiological aspects, Medicine, Experimental -- Physiological aspects, Diabetes therapy -- Physiological aspects, Insulin resistance -- Physiological aspects, Antilipemic agents -- Physiological aspects, Type 2 diabetes -- Physiological aspects, Diabetics -- Physiological aspects, Testosterone -- Physiological aspects, Sexual disorders -- Physiological aspects, Pharmaceutical industry -- Physiological aspects, Health
Abstract

OBJECTIVE--This study evaluated the effects of testosterone replacement therapy (TRT) on insulin resistance, cardiovascular risk factors, and symptoms in hypogonadal men with type 2 diabetes and/or metabolic syndrome (MetS). RESEARCH [...]

Published
2011
Full Text
View/download PDF

2. Statin therapy is associated with lower total but not bioavailable or free testosterone in men with type 2 diabetes

Author

Stanworth, Roger D., Kapoor, Dheeraj, Channer, Kevin S., and Jones, T. Hugh

Subjects
Hypogonadism -- Risk factors -- Diagnosis -- Research -- Complications and side effects -- Drug therapy -- Health aspects, Type 2 diabetes -- Drug therapy -- Complications and side effects -- Research -- Risk factors -- Diagnosis -- Health aspects, Testosterone -- Research -- Health aspects -- Complications and side effects -- Dosage and administration, Health, Drug therapy, Diagnosis, Complications and side effects, Research, Risk factors, Dosage and administration, Health aspects
Abstract

OBJECTIVE--There is a high prevalence of hypogonadism in men with type 2 diabetes. This will lead to an increase in assessments of hypogonadism. Statins could potentially decrease testosterone levels by [...]

Published
2009

3. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity

Author

Kapoor, Dheeraj, Aldred, Hazel, Clark, Stephanie, Channer, Kevin S., and Jones, T. Hugh

Subjects
Hypogonadism -- Diagnosis, Type 2 diabetes -- Diagnosis, Testosterone -- Health aspects, Health, Diagnosis, Health aspects
Abstract

OBJECTIVE--The aim of our study was to assess the prevalence of clinical hypogonadism, based on both symptoms and biochemical available measures of testosterone deficiency, in men with type 2 diabetes. [...]

Published
2007

6. Response to Comment on: Jones et al. Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES 2 Study). Diabetes Care 2011;34:828--837.

Author

JONES, T. HUGH, HOWELL, JULIAN D., and CHANNER, KEVIN S.

Subjects
LETTERS to the editor, TESTOSTERONE, TYPE 2 diabetes
Abstract

A response by T. Hugh Jones to letter to the editor about his article "Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study)," is presented.

Published
2011
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results